Literature DB >> 20700722

A cellular viability assay to monitor drug toxicity.

Jakob Hansen, Peter Bross.   

Abstract

A central part of the research in protein misfolding and its associated disorders is the development of treatment strategies based on ensuring cellular protein homeostasis. This often includes testing chemical substances or drugs for their ability to counteract protein misfolding processes and to promote correct folding. Such investigations also include assessment of how the tested chemical substances affect cellular viability, that is, their cytotoxic effect. Investigations of cytotoxicity often require testing several different concentrations and drug exposure times using cells in culture. It is therefore attractive to use a viability test that permits the analysis of many samples with little handling time. This protocol describes a simple and fast methodology to analyze viability of lymphoblastoid cells and to test putative cytotoxic effects associated with exposure to a chemical substance, here exemplified by celastrol. The natural substance celastrol has been used for many years in traditional Chinese medicine and has subsequently been shown to induce transcription of genes encoding molecular chaperones (heat shock proteins) that are involved in promoting folding of cellular proteins. The well-described colorimetric tetrazolium salt (MTT) assay, which monitors metabolic activity of cultured cells, was adapted to analyze the viability of cells exposed to celastrol. After having established a suitable cell seeding density, the dose-dependence and time-course of viability reduction of lymphoblastoid cells treated with celastrol were determined. It was found that 4- and 24-h exposure to 0.8 microM celastrol reduced the viability of lymphoblastoid cells, with the most severe effect observed at 24 h with MTT reductions approaching 30% of non-exposed cells. For a series of incubations for 24 h, it was found that concentrations as low as 0.2 microM were sufficient to affect the viability, and celastrol concentrations of 0.5 microM reduced the MTT reduction rate to approximately half the level displayed by cells receiving vehicle alone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20700722     DOI: 10.1007/978-1-60761-756-3_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

Review 1.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

2.  Hormesis-based anti-aging products: a case study of a novel cosmetic.

Authors:  Suresh I S Rattan; Valérie Kryzch; Sylvianne Schnebert; Eric Perrier; Carine Nizard
Journal:  Dose Response       Date:  2012-01-12       Impact factor: 2.658

3.  MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a.

Authors:  Ning Wang; Heng Wei; Duo Yin; Yanming Lu; Yao Zhang; Qiao Zhang; Xiaoxin Ma; Shulan Zhang
Journal:  Tumour Biol       Date:  2015-10-28

Review 4.  Getting folded: chaperone proteins in muscle development, maintenance and disease.

Authors:  Daniel A Smith; Carmen R Carland; Yiming Guo; Sanford I Bernstein
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

5.  Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors.

Authors:  Her-Shyong Shiah; Nai-Jung Chiang; Chia-Chi Lin; Chia-Jui Yen; Hui-Jen Tsai; Shang-Yin Wu; Wu-Chou Su; Kwang-Yu Chang; Ching-Chiung Wang; Jang-Yang Chang; Li-Tzong Chen
Journal:  Oncologist       Date:  2020-12-18

6.  Surfactin-Loaded ĸ-Carrageenan Oligosaccharides Entangled Cellulose Nanofibers as a Versatile Vehicle Against Periodontal Pathogens.

Authors:  Athira Johnson; Jia-Ling He; Fanbin Kong; Yi-Cheng Huang; Sabu Thomas; Hong-Ting Victor Lin; Zwe-Ling Kong
Journal:  Int J Nanomedicine       Date:  2020-06-09

7.  A high throughput screen for RGS proteins using steady state monitoring of free phosphate formation.

Authors:  C Aaron Monroy; Duncan I Mackie; David L Roman
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

8.  Determination of cell survival after irradiation via clonogenic assay versus multiple MTT Assay--a comparative study.

Authors:  Karl Buch; Tanja Peters; Thomas Nawroth; Markus Sänger; Heinz Schmidberger; Peter Langguth
Journal:  Radiat Oncol       Date:  2012-01-03       Impact factor: 3.481

9.  Quantitative proteomics reveals cellular targets of celastrol.

Authors:  Jakob Hansen; Johan Palmfeldt; Søren Vang; Thomas J Corydon; Niels Gregersen; Peter Bross
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

10.  Evidence for Detrimental Cross Interactions between Reactive Oxygen and Nitrogen Species in Leber's Hereditary Optic Neuropathy Cells.

Authors:  Micol Falabella; Elena Forte; Maria Chiara Magnifico; Paolo Santini; Marzia Arese; Alessandro Giuffrè; Kristina Radić; Luciana Chessa; Giulia Coarelli; Maria Chiara Buscarinu; Rosella Mechelli; Marco Salvetti; Paolo Sarti
Journal:  Oxid Med Cell Longev       Date:  2015-12-31       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.